News

Fierce Pharma5d
Merck scores FDA nod for Enflonsia, setting up RSV market battle vs. Sanofi and AstraZeneca's Beyfortus
Meanwhile, Sanofi has pointed to Beyfortus’ 75% reduction in the incidence of MALRI versus Enflosia’s figure of 60%. The ...
Newly approved antibody could offer another option for protecting infants from RSV, a common infection that can be deadly
The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...
It has been a long, deadly flu season in Arizona and the virus is still here
The flu virus is lingering in Arizona and the season has been vicious. Pediatric flu deaths reached the highest level in ...
FDA Expands Moderna's RSV Vaccine Use To At-Risk Adults Aged 18–59 Amid CDC Panel Shake-Up
The U.S. Food and Drug Administration expanded approval of Moderna Inc.'s (NASDAQ: MRNA) respiratory syncytial virus vaccine.
Managed Healthcare Executive4d
FDA Approves Enflonsia To Protect Infants During Their First RSV Season
Enflonsia is the first FDA-approved respiratory syncytial virus (RSV) preventative for infants, regardless of weight, according to the news release.
Belfast Live on MSN2d
Details of who is eligible for potentially life-saving RSV jab in Northern Ireland
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
WATE 6 On Your Side on MSN1d
What to know about COVID vaccines for children, pregnant women after RFK Jr.’s change
Public health and infectious disease experts said they were surprised and confused about the move, and questioned why the HHS did not offer any reasoning for its decision.
Spokane Public Radio1d
WA doctor among those fired in RFK Jr.’s purge of vaccine panel
The University of Washington’s Helen Chu, a leading voice in the COVID-19 pandemic, said she’s worried about where the panel ...